Articles published by Endologix LLC
From Endologix LLC
Via Business Wire
From Endologix LLC
Via Business Wire

Endologix Appoints Andrew Davis as Chief Commercial Officer
March 03, 2025
From Endologix LLC
Via Business Wire



Endologix to Present at 22nd Annual Global Morgan Stanley Conference
September 03, 2024
From Endologix LLC
Via Business Wire

From Endologix LLC
Via Business Wire


From Endologix LLC
Via Business Wire

Endologix Appoints Mike Mathias as Chief Commercial Officer
March 05, 2024
From Endologix LLC
Via Business Wire

Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
February 29, 2024
From Endologix LLC
Via Business Wire

Endologix Announces that Art Taylor Joins Board of Directors
January 25, 2024
From Endologix LLC
Via Business Wire

Endologix Announces that Scott Ward Joins Board of Directors
January 09, 2024
From Endologix LLC
Via Business Wire


Endologix to Present in Two Upcoming Healthcare Conferences
November 09, 2023
From Endologix LLC
Via Business Wire




Endologix Announces that Lucas Buchanan Joins Board of Directors
August 24, 2023
From Endologix LLC
Via Business Wire







Endologix Receives FDA Approval of PMA Supplement for AFX2 System
December 07, 2022
From Endologix LLC
Via Business Wire




Endologix Submits Premarket Approval (PMA) Application to FDA for the DETOURTM System.
October 10, 2022
From Endologix LLC
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.